Wanjare et al., 2021 - Google Patents
Nanosuspension: A Promising Approach to Improve Solubility, Dissolution Rate and Bioavailability of Poorly Soluble Drug.Wanjare et al., 2021
- Document ID
- 4245313161257076196
- Author
- Wanjare M
- Sharma P
- Koka S
- Gupta A
- Sharma R
- Darwhekar G
- Publication year
- Publication venue
- International Journal of Pharmacy & Life Sciences
External Links
Snippet
Solubility is a critical element in pharmacological efficacy of drug regardless of the method of administration. The nanosuspension technology can improve the drug's solubility and bioavailability. The fact that many newly discovered drugs are water insoluble and thus …
- 239000003814 drug 0 title abstract description 130
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Joshi et al. | Nanocrystalization: an emerging technology to enhance the bioavailability of poorly soluble drugs | |
Patel et al. | Nanosuspension: An approach to enhance solubility of drugs | |
Yadav et al. | Nanosuspension: A promising drug delivery system | |
CA2604770C (en) | Method for carefully producing ultrafine particle suspensions and ultrafine particles and use thereof | |
Geetha et al. | Various techniques for preparation of nanosuspension-a review | |
Kumar Singh et al. | Nanosuspension: principles, perspectives and practices | |
Paun et al. | Nanosuspension: An emerging trend for bioavailability enhancement of poorly soluble drugs | |
Patel et al. | Nanosuspension: A novel approch to enhance solubility of poorly water soluble drugs-A review | |
Aher et al. | Nanosuspension: an overview | |
Khandbahale | A review-Nanosuspension technology in drug delivery system | |
Shah et al. | Nanosuspension technology: A innovative slant for drug delivery system and permeability enhancer for poorly water soluble drugs | |
Bhowmik et al. | Nanosuspension-A novel approaches in drug delivery system | |
Patel et al. | Nanosuspension technologies for delivery of poorly soluble drugs-a review | |
Chaurasia et al. | A Review on Nanosuspensionspromising Drug Delivery Strategy | |
Chauhan et al. | Micronization of BCS Class–II Drugs by Various Approaches for Solubility Enhancement–A Review | |
Kulkarni et al. | A novel approach towards nanosuspension | |
Sawant et al. | Drug nanocrystals: novel technique for delivery of poorly soluble drugs | |
Wanjare et al. | Nanosuspension: A Promising Approach to Improve Solubility, Dissolution Rate and Bioavailability of Poorly Soluble Drug. | |
Jayalakshmy et al. | Nanosuspension: A method for solubility enhancement | |
Abdulbaqi et al. | Nanosuspension as an innovative nanotechnology trend drug delivery system: A review | |
Singh et al. | Nanosuspension: Way to enhance the bioavailability of poorly soluble drug | |
Ali et al. | Drug nanocrystals: emerging trends in pharmaceutical industries | |
Desu et al. | A review on significance of nanocrystals in drug delivery | |
Badnale et al. | A REVIEW ON “Solid Lipid Nanoparticles”(SLNs) | |
Prajapat et al. | A Systematic Review on Nanosuspension and its advancements. |